申请人:Ebel Heiner
公开号:US08653262B2
公开(公告)日:2014-02-18
The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.
本发明涉及新的CCR2(CC趋化因子受体2)拮抗剂及其用途,用于提供治疗疾病和病症的药物,特别是用于治疗肺部疾病,如哮喘和COPD。